Global Pharma Blister Packaging Market 2024–2033

Reports Description

Global Pharma Blister Packaging Market was valued at USD 24.3 Billion in 2024 and is expected to reach USD 43.6 Billion by 2033, at a CAGR of 6.4% during the forecast period 2024 - 2033.

To learn more about this report - request a sample report PDF

Pharmaceutical blister packaging is the use of thermoformed plastic or aluminium blister packs to safely hold and preserve individual dosages of medication. These blister packs are often made of a backing material, that includes paperboard or foil, with cavities or pockets for the pills, tablets, or capsules.

Pharma Blister Packaging Market Growth Factors

Adoption of cold formed plastics due to more tensile strength

Cold-formed polymers, with their exceptional tensile strength and stiffness features, play an important role in driving the growth of the pharmaceutical blister packaging industry. Unlike typical thermoformed plastics, which are heated and moulded to shape, cold-formed plastics are formed without the use of heat.

This method includes stretching the plastic sheet over a mould cavity with pressure, which results in greater molecular orientation and alignment inside the material. The cold-forming process causes the plastic's molecular structure to become more densely packed, resulting in increased tensile strength and stiffness as compared to thermoformed polymers.

Cold-formed plastics are ideal for pharmaceutical blister packaging applications that need the protection and preservation of sensitive medication formulations due to their increased mechanical strength.

Cold-formed plastics' improved tensile strength and stiffness assurance that the blister packaging retains structural integrity during handling, shipping, and storage, protecting the pharmaceutical goods within. Furthermore, the durability of cold-formed plastic blister packs provides tamper-evident characteristics, giving consumers confidence in the product's legitimacy and safety.

Ultimately, cold-formed plastics' outstanding mechanical qualities make them a popular choice for pharmaceutical blister packaging, boosting market growth as pharmaceutical businesses prioritize safeguarding goods, and compliance.

Advanced manufacturing processes

Advanced manufacturing technologies are transforming the pharmaceutical blister packaging industry by increasing efficiency, accuracy, and product integrity. These procedures, which include thermoforming, cold forming, and heat sealing, provide several benefits that fuel industry innovation and growth.

Thermoforming, for example, uses heat and pressure to shape plastic sheets into exact forms, enabling the creation of customized blister packs based on specific medicine compositions.

Cold forming, on the other hand, uses pressure alone to shape aluminium foil into blister chambers, resulting in higher barrier characteristics and protection against moisture, oxygen, and light. Heat sealing methods provide secure and tamper-evident seals, extending the quality and lifespan of pharmaceutical items.

Furthermore, new manufacturing methods enable the incorporation of smart packaging elements such as RFID tags, QR codes, and temperature sensors, allowing for track-and-trace abilities, verification, and real-time monitoring of product conditions.

This improves supply chain visibility, regulatory compliance, and patient safety. Overall, the use of advanced manufacturing processes in pharmaceutical blister packaging improves efficiency, quality, and inventiveness, meeting the industry's evolving demands for safe, dependable, and user-friendly packaging options while maintaining pharmaceutical item integrity and effectiveness.

Pharma Blister Packaging Market: Restraints

Price volatility of raw materials

The volatile prices of raw materials have a substantial influence on the pharmaceutical blister packaging business. The fluctuations in the pricing of materials used in blister packaging, such as plastics, aluminium, and paperboard, can cause uncertainty and instability in pharmaceutical businesses' manufacturing costs.

This unpredictability can disrupt supply chains, strain profit margins, and pose problems to blister packaging makers' pricing plans. Furthermore, rapid price spikes in raw materials may force manufacturers to pass on the additional costs to pharmaceutical firms, resulting in increased packaging costs for medication producers.

As a result, pharmaceutical companies may seek alternate packaging options or suppliers to reduce costs, hence influencing market demand for blister packaging.

Pharma Blister Packaging Market: Opportunities

Innovation in recyclable materials

Innovations in recyclable materials are transforming the pharmaceutical blister packaging business by meeting environmental concerns and regulatory requirements. These innovations enable the creation of eco-friendly packaging solutions that reduce environmental impact while adhering to tight waste management requirements.

Recyclable materials that include bio-based plastics, compostable polymers, and recycled plastics provide viable alternatives to typical blister packaging materials like PVC and aluminium, which are non-biodegradable and difficult to recycle.

Pharmaceutical firms may improve their environmental stewardship, minimize their carbon footprint, and fulfil customer demand for sustainable packaging by utilizing recyclable materials. Furthermore, improvements in recyclable materials create cost savings by lowering raw material costs, waste disposal fees, and compliance fines. As an outcome, pharmaceutical blister packaging producers are progressively investing in R&D.

Novel blister film, made of PP, is recyclable and fits the unique criteria of the pharmaceutical business. SUDPACK developed a novel coextrusion technique to create the high-performance top and bottom webs of PharmaGuard.

Pharma Blister Packaging Market: Segmentation Analysis

Global Pharma Blister Packaging market is segmented by material, technology, application, and region. Based on material, the market is classified into polyethylene terephthalate, polyethylene, polyvinyl chloride, aluminium, paper & paper board and others. Polyethylene Terephthalate dominated the market in 2023 with a market share of 30.3% and is expected to keep its dominance during the forecast period 2024-2033.

Polyethylene Terephthalate (PET) plays a pivotal role in driving the pharmaceutical blister packaging market due to its distinctive combination of properties. PET has exceptional clarity, durability, and barrier qualities against oxygen, moisture, and light, making it a perfect material for preserving pharmaceutical items from environmental factors.

Furthermore, PET is lightweight, cost-effective, and easily recyclable, which aligns with pharmaceutical firms' environmental aims. Its adaptability enables for customization in terms of size, shape, and design, according to the individual requirements of various medication formulations and dosage formats. Moreover, PET blister packaging enhances tamper resistance and product integrity, which improves patient safety and compliance.

Based on technology, the market is classified into coldforming and thermoforming. Cold sealing dominated the market in 2023 with a market share of 59.5% and is expected to keep its dominance during the forecast period 2024-2033. Cold sealing technology is transforming the blister packaging equipment market, providing various advantages over traditional heat sealing processes.

Unlike heat sealing, which needs high temperatures and may harm fire-sensitive items, cold sealing uses pressure-sensitive glue to connect the blister packing material without the use of heat. This soft sealing procedure is very useful for packing sensitive objects including medications, electronics, and food products.

The growth of cold sealing technology has resulted in a growing demand for blister packing equipment that uses this novel sealing process. Manufacturers are expanding their investments in cold sealing equipment to suit the increased demand for heat-sensitive product packaging.

Moreover, cold sealing saves energy usage, production costs, and cycle times, making it an appealing solution for businesses seeking efficiency and sustainability in their packaging operations.

Based on end user, the market is classified into tablets, capsules, drugs, vials, ampoules and others. Tablets dominated the market in 2023 with a market share of 35.8% and are expected to keep their dominance during the forecast period 2024-2033. Tablets play an important role in driving growth in the pharmaceutical blister packaging industry.

Tablets, which are the recommended dose form for many pharmaceuticals, require dependable and secure packaging to ensure efficacy and longevity. Blister packaging provides various benefits for tablets, including protection from moisture, light, and air, as well as convenience of handling and dosage for patients.

This increases demand for blister packaging solutions designed particularly for tablets, resulting in advancements in package design, materials, and technology. Moreover, the growing number of drugs offered over-the-counter (OTC) and the rising frequency of chronic conditions necessitating long-term prescription regimens are driving up demand for blister packaging for tablets.

Blister packs are extremely popular among customers due to their ease, portability, and tamper-evident characteristics, which drive growth in the pharmaceutical blister packaging market.

Report Scope

Pharma Blister Packaging Market: Regional Analysis

By region, Pharma Blister Packaging market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa. North America dominated the global Pharma Blister Packaging market in 2023 with a market share of 41.6% and is expected to keep its dominance during the forecast period 2024-2033.

North America has a developed pharmaceutical sector with strong research and development efforts, resulting in a significant need for new and sophisticated packaging solutions. Furthermore, strict requirements and quality standards enforced by regulatory organizations such as the FDA require the use of secure and tamper-evident packaging to assure product safety and compliance.

Moreover, the rising frequency of chronic illnesses and an aging population in North America boost pharmaceutical demand, highlighting the significance of effective and safe packaging options such as blister packs.

Additionally, the presence of significant pharmaceutical businesses and packaging manufacturers in the region, together with investments in technology and automation, accelerates market expansion. In conclusion, North America's significant pharmaceutical sector, regulatory environment, and healthcare environment all contribute to the expansion of the pharma blister packaging market in the region.

Pharma Blister Packaging Market Recent Developments

• In October 2023, Solvay, a worldwide industry leader in specialty materials, released Diofan® Ultra736, a new polyvinylidene chloride (PVDC) coating solution with an ultra-high water vapour barrier that reduces the carbon footprint of pharmaceutical blister films.

• In April 2021, Amcor launched the first recyclable* polyethylene-based thermoform blister packaging. AmSky™ removes PVC (PolyVinyl Chloride) from the packaging by employing a Polyethylene (PE) thermoform blister and lidding film.

• In October 2023, PA and PulPac created the foundational technology required to create a functional Dry Moulded Fibre tablet blister pack. The usage of Dry Moulded Fibre pill packs gives a chance to reduce the more than 100,000 tonnes of plastic pharmaceutical packaging used each year.

List of the prominent players in the Pharma Blister Packaging Market:

• Amcor plc
• Bemis Company Inc.
• Berry Global Group Inc.
• WestRock Company
• Constantia Flexibles Group GmbH
• Gerresheimer AG
• Klöckner Pentaplast Group
• Sonoco Products Company
• Uflex Ltd.
• Tekni-Plex Inc.
• Winpak Ltd.
• Bilcare Limited
• Sealed Air Corporation
• Mitsubishi Chemical Holdings Corporation
• Schott AG
• Huhtamäki Oyj
• Intrapac International Corporation
• Wipak Group
• Drug Plastics & Glass Co. Inc.
• Mondi Group
• Others

These key players are adopting various growth strategies such as mergers & acquisitions, joint ventures, expansion, strategic alliances, new product launches, etc. to enhance their business operations and revenues.

The Pharma Blister Packaging Market is segmented as follows:

By Material

• Polyethylene Terephthalate
• Polyethylene
• Polyvinyl Chloride
• Aluminium
• Paper & Paper Board
• Others

By Technology

• Coldforming
• Thermoforming

By Application

• Tablets
• Capsules
• Drugs
• Vials
• Ampoules
• Others

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America